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Pancreatic secretory factor (PSF), an efficient pancreatic secretagogue recently isolated from the venom 
of Heloderma suspecturn, is shown to exert phospholipase AZ activity towards phosphatidylcholine. This 
activity is strictly dependent on calcium (apparent K, 40 nM) and has an optimum pH around 9. At pH 7.4 
and in the presence of calcium, PSF retains 40% of its phospholipase A2 activity. These results are 
compared to the calcium dependency of the secretory effect of PSF on rat pancreatic acini. Taken 
collectively, the present data on PSF suggest hat a similar endogenous phospholipase A2 activity might 
be involved in the late steps of stimulus-secretion coupling in the exocrine pancreas. 
Rat pancreatic acini Amylase secretion Pancreatic secretory factor 
Gila Monster -venom 
1. INTRODUCTION 2. MATERIALS AND METHODS 
The venom from the lizard Heloderma suspec- 
turn stimulates the release of amylase and the pro- 
duction of cyclic AMP by guinea pig [l] and rat [2] 
pancreatic acini. We demonstrated recently that 
these two effects are unrelated in rat pancreatic 
acini: a VIP-like component is indeed responsible 
for the cyclic AMP production while the secretory 
effect is due to a 17.5kDa protein that neither 
modifies cyclic AMP concentration nor alters cal- 
cium movements. We named this protein pan- 
creatic secretory factor (PSF) [3-51. We report 
here that PSF is a calcium-dependent phospho- 
lipase Al (pH optimum 9.0) whose secretory action 
might suggest a similar contribution of endo- 
genous phospholipase AZ activity to stimulus- 
secretion coupling in the rat exocrine pancreas. 
2. I. Materials 
L-3-Phosphatidylcholine from egg yolk, phos- 
pholipase A2 (phosphatide 2-acylhydrolase, EC 
3.1.1.4) from Naja naja venom and all phospho- 
lipid standards were from Sigma (St. Louis, MO). 
I-Palmitoleyl-2-[l-‘4C]oleoyl-L-3-phosphatidyl- 
choline was from Amersham (Bucks) Chaps 
[3 - ( (3 - cholamidopropyl)dimethylammonio ] - 1 - 
pro-panesulfonate] was purchased from Poly- 
sciences (Warrington, PA). C-terminal octapeptide 
of cholecystokinin (CCK-8) was a gift from Dr J. 
Lucania (Squibb Institute for Medical Research, 
Princeton, NJ) and synthetic secretin a gift from 
Dr W. Konig (Hoechst Aktiengesellschaft, Frank- 
furt/M.). PSF from Gila Monster venom was 
isolated as in [3]. 
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2.2. Methods 
2.2.1. Phospholipase A2 activity 
L-3-Phosphatidylcholine from egg yolk at a 
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final concentration of 0.5 mg/ml was sonicated for 
5 s in 1OOmM Tris-Mops buffer (pH 8.5), in 
the presence of 1.2 mg/ml Chaps, 5 mM CaClz 
and 110000 cpm l-palmitoleyl-2-[l-14C]oleoyl-L-3- 
phosphatidylcholine. Pure PSF [3] and phospho- 
lipase A2 from N. naju venom (PLA2) were added 
in a volume of 10~1. The final incubation volume 
was 0.5 ml. After enzyme addition, the tubes were 
mixed for 30s and incubated with continuous 
shaking at room temperature for 10 min. The reac- 
tion was stopped by adding 2 ml CHC4/CH3OH/ 
HCl (200: 100: 3). After centrifugation at 4°C for 
5 min at 2500 x g, the upper phase was discarded 
and the lower phase was washed with 0.5 ml of 1% 
HCl and 1 ml CHC13/CH3OH/HCl (200: 100: 3). 
After centrifugation, the lower phase was evapor- 
ated to dryness at 40°C under a stream of N2. The 
lipids were dissolved in 200~1 CHCl3/CH3OH/HCl 
(200 : 100 :3). A 10~1 aliquot was layered on a silica 
gel plate (Kieselgel 60F-254, 0.2 mm thick, Merck, 
Darmstadt) and eluted with CHCI~/CH~OH/NHJ 
(105 :45 :7.5). Lipids were visualized by iodine 
vapour and identified with reference to standards. 
The plate was cut and fragments were placed into 
scintillation glass vials containing 1 ml CHJOH. 
After mixing, 8 ml Aquasolve 2 (New England 
Nuclear, Dreieich) were added and the vials were 
counted in an LS-8000 Beckman liquid spectro- 
meter. 
2.2.2. Amylase secretion 
Rat pancreatic acini were isolated and incubated 
as in [6]. After washing, the acini were incubated 
for 30min in the standard incubation medium, in 
the presence of 0.5 mM Ca2+ or 0.1 mM EGTA. 
Amylase released in the medium was assayed as in 
]71. 
3. RESULTS AND DISCUSSION 
As shown in table 1, PSF was able to release 
[ l-‘4C]oleic acid from the glycerol 2-position of a 
labelled lecithin. This activity was comparable to 
that of a commercial phospholipase A2 isolated 
from the venom of N. naja. The optimum pH of 
PSF activity was about 9.0, this activity being 
reduced by 60% at pH 7.4 (fig.lA). This activity 
was highly dependent on the presence of calcium, 
the enzyme being inactive at Ca2+ con entrations 
E+ below 1 nM and maximally active at Ca, concen- 
trations around 1pM (fig.lB). The apparent half- 
maximal effective Ca2+ concentration of 40 nm 
reflected a true & value [8] as it did not’vary when 
PSF concentration was increased from 1’ to 100 nM 
(not shown). Similarly, the secretory effect of PSF 
on rat pancreatic acini depended entirely on the 
presence of extracellular calcium (table 2). This 
effect was completely abolished when the acini 
were incubated for 30 min in the presence of 
0.1 mM EGTA (instead of 0.5 mM Ca2+), whereas 
the secretory effects of optimal concentrations of 
carbamylcholine, CCK-8 and secretin were only 
halved. 
PSF is thus an extracellular phospholipase A2 
extracted from the venom of the lizard H. suspec- 
turn that is thermostable, lipophilic and acidic and 
can be added to the list of similar enzymes present 
in the venom of snakes, bees and scorpions [9], Its 
optimum pH is around 9 and its activity strictly 
calcium-dependent, with a relatively low concen- 
tration requirement for the cation. The secretory 
effect of PSF on rat pancreatic acini is also depen- 
dent on extracellular calcium and is not accom- 
panied by changes in cyclic AMP concentration or 
calcium efflux.[2,5]. 
Table 1 
Phospholipase A2 activity of purified pancreatic secretory factor from Gila Monster venom 
Enzyme Radioactivity distribution (To) in 
L-3-Phosphatidylcholine Fatty acid I-Acyllysophosphatidylcholine 
Control 96.2 + 0.5 1.6 + 0.2 2.2 + 0.54 
20nM PSF 72.8 f 1.4 23.8 -t 1.2 3.4 + 0.3 
PLAz (4 units/ml) 72.9 f 2.6 25.3 + 1.5 1.8 + 0.4 
Phospholipase activity was measured as described in section 2. Results are expressed as percentage of total radioactivity 
found in the 3 major classes of lipids, namely, L-3-phosphatidylcholine, lysophosphatidylcholine and free fatty acids, 
and are means of 3 experiments 2 SE 
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PHOSPHOLIPASE A? ACTIVITY OF PSF 
A/ pH DEPENDENCY 8/ Cd 2+ DEPENDENCY 
b I 8 Y IO _I0 -8 -6 -4 -2 
PH i Ca2* CONC] (log M ) 
Fig.1. (A) The phospholipase A2 assay was carried out 
as described in section 2, except for the pH which varied 
between 6 and 10. The assay was performed for 10min 
in the presence of 5 mM CaClz and 20 nM PSF. This ex- 
periment is representative of 3 experiments. (B) Phos- 
pholipase AZ activity was measured for 10 min at pH 9 as 
described in section 2, except for the concentration of 
free calcium which varied from 0 to 1 mM. Calcium- 
ECTA buffers (0) allowed calcium concentrations up to 
1 PM. Dilutions from a 100 mM CaC12 stock solution were 
used for concentrations ranging from 1 to 5 mM (0). 
This experiment is representative of four experiments. 
The calcium dependency of the two effects of 
PSF and the fact that its phospholipase AZ activity 
extends to pH 7.4 in the presence of calcium 
(fig.lA) suggest that the release of amylase de- 
pends on pancreatic phospholipids. The hyper- 
secretion does not merely reflect the escape of 
hydrolases from leaking cell membranes ince: (i) 
this effect is fully reversible when PSF is removed 
from the medium [5]; (ii) PSF does not provoke 
Table 2 
Effects of Ca2+ and EGTA on amylase secretion from 
rat pancreatic acini stimulated by various secretagogues 
Secretagogue 0.5 mM Ca2+ 0.1 mM EGTA 
Control 2.0 + 0.4 1.8 _t 0.4 
30nM PSF 9.3 f 1.3 1.7 f 0.7 
5,~uM carbamylcholine 14,9 + 3.2 8.1 + 0.8 
3 nM CCK-8 13.1 f 3.8 7.6 + 1.9 
3aM secretin 7.4 l?z 2.8 4.4 + 1.4 
Results are expressed as percentage of total amylase con- 
tent released in the medium during the incubation and 
are means of 3 experiments + SE 
the leakage of lactate d~hydrogenase from rat pan- 
creatic acini 15); (iii) PSF does not modify the suc- 
rose space of pancreatic acini (not shown); (iv) 
PSF does not hemolyse washed human red blood 
cells incubated for 30 min with 130 mM NaCl con- 
taining 1 mM CaClz and buffered to pH 7.4 by 
20mM Hepes (not shown). Thus, like other acidic 
phospholipases AZ, PSF may well be less toxic than 
basic phospholipases A2 [ 10,111. Taken together, 
our data are consistent with the hypothesis that a 
limited pool only of pancreatic phospholipids is 
available to hydrolysis by PSF 1121. 
Up to now, phospholipase C has attracted greater 
interest than phospholipase At because of its in- 
volvement in the calcium-independent degradation 
of (poIy)phosphatidylinositols that may well be a 
mediator of membrane calcium gating in glands 
stimulated by natural secretagogues. This model 
appears to apply to receptors for muscarinic drugs, 
cholecystokinin, and bombesin that are present at 
the blood front of rat pancreatic acinar cells and 
control protein secretion through Ca2+ mobiliza- 
tion [13-l 81. It does not apply, however, to secre- 
tin receptors that do not couple secretion to Ca2’ 
mobilization: the secretagogue secretin does not 
provoke a phosphatidylinositol response [ 171 but 
can, like the ionophore A23187, bypass the phos- 
phatidylinositol cycle. Recently, two indirect lines 
of evidence indicated that intracellular phospholi- 
pase At activity might contribute to stimulus-secre- 
tion coupling in the exocrine pancreas: (i) the rat 
pancreas contains variously repressed forms of 
phospholipase A2 that may coexist as soluble and 
membrane-associated ntities (as in several mam- 
malian tissues) and as a zymogen-bound form 
[9,10,19,20]; (ii) carbamylcholine and ionomycin 
(a calcium ionophore) increase deacylation-reacyla- 
tion processes at position 2 of phospholipids in rat 
pancreatic acini [21]. We would like to suggest hat 
the interaction between phospholipases C and AZ 
121,221 may be vizualized in terms of subsequent 
events: the action of the first enzyme on (poly)phos- 
phatidylinositols is close to receptors at the basal 
front of acinar cells whereas Ca’+-dependent acti- 
vation of intracellular phospholipase A2 would be 
closer to the secretory pole [19] and might be a late 
event leading to the release of hydrolases in re- 
sponse to all natural secretagogues, including 
secretin. A similar contribution of phospholipase 
AZ has been suggested in pancreaticj? cells, adrenal 
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gland [24], anterior pituitary releasing PRL [25], 
mast cells [26] and neurons [27]. In the rat exocrine 
pancreas uch an involvement of phospholipase AZ 
might conceivably set two mechanisms into play: 
(i) arachidonic acid released in acinar cells might 
be converted into prostaglandins and hydroxy 
acids, via the cyclooxygenase and lipoxygenase 
pathways, respectively [28]. However, the meta- 
bolic significance of such an ‘arachidonic acid cas- 
cade’ is unlikely for two reasons: (i) exogenous 
arachidonic acid, when used at high concentration, 
induces amylase secretion from the rat pancreas 
(even in the presence of indomethacin) but exo- 
genous PGE2 and PGF2 are unable to exert this 
effect (review [29]). In addition 5,8,1 l,lCeico- 
satetraynoic acid (ETYA) and nordihydro- 
guaiaretic acid (two inhibitors of the cyclooxygen- 
ase and lipoxygenase pathways) inhibit the synthe- 
sis of arachidonic acid derivatives in response to 
the calcium ionophore ionomycin without altering 
amylase secretion [30]; (ii) our data are more com- 
patible with a second hypothesis: lysophospho- 
lipids are fusogens of cellular membranes [31] 
whose cytotoxic action may be prevented by rapid 
reacylation via rat pancreatic acyl-CoA : lysophos- 
pholipid acyltransferase activity [32]. The present 
data obviously warrant further study of several 
parameters including the localisation and activa- 
tion of various phospholipases as well as the re- 
acylation and flip-flow capacity of (lyso)phospho- 
lipids at different fronts of the pancreatic acinar 
cell. 
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